Please Implement a consistent shared care agreement for ADHD medication
Please Implement a consistent shared care agreement for ADHD medication
The Issue
For parents like myself, the struggle to ensure our children receive the necessary medical care can be a heavy burden. My son, aged 21, who is diagnosed with profound autism and ADHD, has seen his life disrupted simply because a shared care agreement hasn't been established between healthcare providers for his ADHD medication. This has not only affected his therapeutic care but has left him and others like him in a vulnerable position.
The discontinuation of his medication has led to a noticeable decline in his daily functioning, impacting his ability to engage with his environment and progress in his personal development. Many individuals in the UK are facing similar challenges. Without a consistent, clear, and universal shared care agreement across GP practices, countless people with ADHD are left without the medications they depend upon for quality of life.
Shared care agreements facilitate the joint management of patients between specialists and GPs, ensuring continuity and coherence in treatment plans. Their absence creates a significant gap in care, affecting patients with complex needs who require regular, monitored treatment like ADHD medication. It is imperative that GP practices across the UK adopt a uniform approach to shared care agreements, so that no one is left in a precarious situation without their essential medications.
A national policy mandating consistent shared care agreements would streamline patient management, reduce the administrative burden on healthcare providers, and most importantly, safeguard the health and well-being of patients. Such a change can prevent instances like my son’s from recurring, allowing individuals to continue receiving the care they need without interruption.
Please join me in urging healthcare authorities to implement a resilient and widespread shared care agreement policy for ADHD medication in the UK. Your signature will contribute to making a substantial difference in the lives of many who face similar struggles. Together, we can advocate for a healthcare system that leaves no patient behind. Sign this petition today to bring about the change that is so desperately needed.
The discontinuation of his medication has led to a noticeable decline in his daily functioning, impacting his ability to engage with his environment and progress in his personal development. Many individuals in the UK are facing similar challenges. Without a consistent, clear, and universal shared care agreement across GP practices, countless people with ADHD are left without the medications they depend upon for quality of life.
Shared care agreements facilitate the joint management of patients between specialists and GPs, ensuring continuity and coherence in treatment plans. Their absence creates a significant gap in care, affecting patients with complex needs who require regular, monitored treatment like ADHD medication. It is imperative that GP practices across the UK adopt a uniform approach to shared care agreements, so that no one is left in a precarious situation without their essential medications.
A national policy mandating consistent shared care agreements would streamline patient management, reduce the administrative burden on healthcare providers, and most importantly, safeguard the health and well-being of patients. Such a change can prevent instances like my son’s from recurring, allowing individuals to continue receiving the care they need without interruption.
Please join me in urging healthcare authorities to implement a resilient and widespread shared care agreement policy for ADHD medication in the UK. Your signature will contribute to making a substantial difference in the lives of many who face similar struggles. Together, we can advocate for a healthcare system that leaves no patient behind. Sign this petition today to bring about the change that is so desperately needed.
18
The Issue
For parents like myself, the struggle to ensure our children receive the necessary medical care can be a heavy burden. My son, aged 21, who is diagnosed with profound autism and ADHD, has seen his life disrupted simply because a shared care agreement hasn't been established between healthcare providers for his ADHD medication. This has not only affected his therapeutic care but has left him and others like him in a vulnerable position.
The discontinuation of his medication has led to a noticeable decline in his daily functioning, impacting his ability to engage with his environment and progress in his personal development. Many individuals in the UK are facing similar challenges. Without a consistent, clear, and universal shared care agreement across GP practices, countless people with ADHD are left without the medications they depend upon for quality of life.
Shared care agreements facilitate the joint management of patients between specialists and GPs, ensuring continuity and coherence in treatment plans. Their absence creates a significant gap in care, affecting patients with complex needs who require regular, monitored treatment like ADHD medication. It is imperative that GP practices across the UK adopt a uniform approach to shared care agreements, so that no one is left in a precarious situation without their essential medications.
A national policy mandating consistent shared care agreements would streamline patient management, reduce the administrative burden on healthcare providers, and most importantly, safeguard the health and well-being of patients. Such a change can prevent instances like my son’s from recurring, allowing individuals to continue receiving the care they need without interruption.
Please join me in urging healthcare authorities to implement a resilient and widespread shared care agreement policy for ADHD medication in the UK. Your signature will contribute to making a substantial difference in the lives of many who face similar struggles. Together, we can advocate for a healthcare system that leaves no patient behind. Sign this petition today to bring about the change that is so desperately needed.
The discontinuation of his medication has led to a noticeable decline in his daily functioning, impacting his ability to engage with his environment and progress in his personal development. Many individuals in the UK are facing similar challenges. Without a consistent, clear, and universal shared care agreement across GP practices, countless people with ADHD are left without the medications they depend upon for quality of life.
Shared care agreements facilitate the joint management of patients between specialists and GPs, ensuring continuity and coherence in treatment plans. Their absence creates a significant gap in care, affecting patients with complex needs who require regular, monitored treatment like ADHD medication. It is imperative that GP practices across the UK adopt a uniform approach to shared care agreements, so that no one is left in a precarious situation without their essential medications.
A national policy mandating consistent shared care agreements would streamline patient management, reduce the administrative burden on healthcare providers, and most importantly, safeguard the health and well-being of patients. Such a change can prevent instances like my son’s from recurring, allowing individuals to continue receiving the care they need without interruption.
Please join me in urging healthcare authorities to implement a resilient and widespread shared care agreement policy for ADHD medication in the UK. Your signature will contribute to making a substantial difference in the lives of many who face similar struggles. Together, we can advocate for a healthcare system that leaves no patient behind. Sign this petition today to bring about the change that is so desperately needed.
Support now
18
The Decision Makers
Petition Updates
Share this petition
Petition created on 17 December 2025